Syncom Formulation (India) Ltd

NSE: SYNCOMF · BSE: 524470 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹20.05
Market cap: ₹1,885 Cr
Revenue (annual): ₹489.2 Cr
Net profit (annual): ₹76.44 Cr
P/E (TTM): 22.0×Sector 50.4×
Promoter holding: 50.57%+0.00% QoQ
FII holding: 0.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

26 Sep 2026 14:16 IST BSE

Other Announcement

Syncom Formulation (India) Other Announcement

Syncom Formulations' promoters have voluntarily waived their right to the proposed final dividend of ₹0.10 per share. This waiver reduces total dividend payout obligations.

Value: ₹4.75 Cr

Read the filing ↗